This suggests that there may be significant differences in biological characteristics, clinical manifestations, treatment response, and prognosis.
← all excerpts
Exploring changes in metabolites and fecal microbiota of advanced gastric cancer based on plasma metabolomics and 16S rDNA sequencing.
1
—
—